Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer
This is a two-part study. Part I is an observational study. Part II is a randomized clinical trial to see how well medical nutrition therapy works compared with standard care in treating patients with lung cancer, pancreatic cancer, or stage III or stage IV prostate cancer.
Checked against the public recordLast updated Oct 3, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Rutgers, The State University of New Jersey
- Interventions being studied
- Behavioral: Medical nutrition therapy; Behavioral: Standard Care
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
DISEASE CHARACTERISTICS: * Diagnosed with one of the following: * Pancreatic cancer * Lung cancer * Stage III or IV prostate cancer * Undergoing treatment at The Cancer Institute of New Jersey * Are undergoing chemotherapy (part 2 only) * Has lost ≥ 5% of their usual body weight in the previous 6 months (part 2 only) PATIENT CHARACTERISTICS: * Life expectancy \> 60 days * Must speak and read English * Accessible in person or by phone for completing questionnaires * Not pregnant or nursing PRIOR CONCURRENT THERAPY: * See Disease Characteristics
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical SchoolNew Brunswick, New Jersey
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 3, 2023. Always confirm current availability with the study team.